Skip to content

Clinical trials

Chronic Periodontitis trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Periodontitis Phase: Not applicable Clear all

153 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20083
20103
20117
20128
201312
201422
201510
201614
201714
201811
20199
20205
20214
20228
20235
20246
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Unknown status29
Recruiting7
Active, not recruiting4
Terminated4
Not yet recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cairo University13
Postgraduate Institute of Dental Sciences Rohtak5
University of Sao Paulo5
Ataturk University4
Kırıkkale University4
Meenakshi Ammal Dental College and Hospital4
Universidade Estadual Paulista Júlio de Mesquita Filho4
Bulent Ecevit University3
Government College of Dentistry, Indore3
Marmara University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Periodontitis153
Periodontitis37
Periodontal Diseases18
Diabetes Mellitus9
Diabetes Mellitus, Type 29
Periodontal Pocket7
Aggressive Periodontitis4
Cardiovascular Diseases3
Atherosclerosis2
Furcation Defects2

Trials

Showing 26 to 50 of 153. Each trial links to its page on Pharma Observatory.

53 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.